These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15751740)

  • 1. Hepatotoxicity of antifungal agents.
    Song JC; Deresinski S
    Curr Opin Investig Drugs; 2005 Feb; 6(2):170-7. PubMed ID: 15751740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical hepatotoxicity associated with antifungal agents.
    Kyriakidis I; Tragiannidis A; Munchen S; Groll AH
    Expert Opin Drug Saf; 2017 Feb; 16(2):149-165. PubMed ID: 27927037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal agents and liver toxicity: a complex interaction.
    Tverdek FP; Kofteridis D; Kontoyiannis DP
    Expert Rev Anti Infect Ther; 2016 Aug; 14(8):765-76. PubMed ID: 27275514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hepatitis during ketoconazole therapy.
    Okumura H; Aramaki T; Satomura K; Iizuka K; Ohta M; Katsuta Y; Akaike M; Terada H; Kusunoki T
    Gastroenterol Jpn; 1983 Apr; 18(2):142-7. PubMed ID: 6303886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Hepatotoxicity with Treatment Doses of Flucytosine and Amphotericin B for Invasive Fungal Infections.
    Folk A; Cotoraci C; Balta C; Suciu M; Herman H; Boldura OM; Dinescu S; Paiusan L; Ardelean A; Hermenean A
    Biomed Res Int; 2016; 2016():5398730. PubMed ID: 26949702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatotoxicity of antimicrobial agents.
    Brown SJ; Desmond PV
    Semin Liver Dis; 2002; 22(2):157-67. PubMed ID: 12016547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subacute mitochondrial liver disease in a patient with AIDS: possible relationship to prolonged fluconazole administration.
    Guillaume MP; De Prez C; Cogan E
    Am J Gastroenterol; 1996 Jan; 91(1):165-8. PubMed ID: 8561126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis attributed to the use of terbinafine].
    Boldewijn OY; Ottervanger JP; Mostart CM; Janssens AR; Calame J; Jonkers GJ
    Ned Tijdschr Geneeskd; 1996 Mar; 140(12):669-72. PubMed ID: 8668241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terbinafine-associated hepatotoxicity.
    Ajit C; Suvannasankha A; Zaeri N; Munoz SJ
    Am J Med Sci; 2003 May; 325(5):292-5. PubMed ID: 12792250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic dysfunction and ketoconazole therapy.
    Svejgaard E; Ranek L
    Ann Intern Med; 1982 Jun; 96(6 Pt 1):788-9. PubMed ID: 6283980
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.
    Fontana RJ; Cirulli ET; Gu J; Kleiner D; Ostrov D; Phillips E; Schutte R; Barnhart H; Chalasani N; Watkins PB; Hoofnagle JH
    J Hepatol; 2018 Dec; 69(6):1317-1325. PubMed ID: 30138689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe hepatitis associated with ketoconazole therapy for chronic mucocutaneous candidiasis.
    Tkach JR; Rinaldi MG
    Cutis; 1982 May; 29(5):482-4. PubMed ID: 6284445
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis and ketoconazole therapy.
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1058-9. PubMed ID: 6271330
    [No Abstract]   [Full Text] [Related]  

  • 15. Terbinafine-induced liver injury.
    Kaushal M; Tolani P; Kumar N; Sharma S
    Natl Med J India; 2017; 30(6):321-323. PubMed ID: 30117442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of cross-hepatotoxicity between voriconazole and posaconazole.
    Foo H; Gottlieb T
    Clin Infect Dis; 2007 Sep; 45(6):803-5. PubMed ID: 17712772
    [No Abstract]   [Full Text] [Related]  

  • 17. Ketoconazole and hepatic reactions.
    Boughton K
    S Afr Med J; 1983 Jun; 63(25):955. PubMed ID: 6304923
    [No Abstract]   [Full Text] [Related]  

  • 18. Invasive mycoses: strategies for effective management.
    Kontoyiannis DP
    Am J Med; 2012 Jan; 125(1 Suppl):S25-38. PubMed ID: 22196206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toxic hepatitis caused by ketoconazole].
    Ned Tijdschr Geneeskd; 1983 Jun; 127(25):1114-5. PubMed ID: 6308481
    [No Abstract]   [Full Text] [Related]  

  • 20. [Liver toxicity of drugs of plant origin].
    Stickel F; Seitz HK; Hahn EG; Schuppan D
    Z Gastroenterol; 2001 Mar; 39(3):225-32, 234-7. PubMed ID: 11324140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.